{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:40:48Z","timestamp":1790764848912,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,9,26]],"date-time":"2013-09-26T00:00:00Z","timestamp":1380153600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00467-013-2605-6","type":"journal-article","created":{"date-parts":[[2013,9,25]],"date-time":"2013-09-25T15:55:12Z","timestamp":1380124512000},"page":"85-94","source":"Crossref","is-referenced-by-count":34,"title":["C3 nephritic factor associated with C3 glomerulopathy in children"],"prefix":"10.1007","volume":"29","author":[{"given":"Camille","family":"Nicolas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Vuiblet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Baudouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Alice","family":"Macher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabele","family":"Vrillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Biebuyck-Gouge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Dehennault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Gi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Nivet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Ulinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Ranchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiarra","family":"Marinozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Fr\u00e9meaux-Bacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Pietrement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,26]]},"reference":[{"issue":"8","key":"2605_CR1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrneph.2010.85","volume":"6","author":"F Fakhouri","year":"2010","unstructured":"Fakhouri F, Fremeaux-Bacchi V, Noel LH, Cook HT, Pickering MC (2010) C3 glomerulopathy: a new classification. Nat Rev Nephrol 6(8):494\u2013499","journal-title":"Nat Rev Nephrol"},{"key":"2605_CR2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2215\/CJN.07110810","volume":"6","author":"S Sethi","year":"2011","unstructured":"Sethi S, Fervenza F, Zhang Y, Nasr S, Leung N, Vrana J, Cramer C, Nester C, Smith R (2011) Proliferative Glomerulonephritis secondary to dysfunction of the alternative pathway of complement. Clin J Am Soc Nephrol 6:1009\u20131017","journal-title":"Clin J Am Soc Nephrol"},{"key":"2605_CR3","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1681\/ASN.2007030356","volume":"18","author":"R Smith","year":"2007","unstructured":"Smith R, Alexander J, Barlow P (2007) New approaches to the treatment of dense deposit disease. J Am Soc Nephrol 18:2447\u20132456","journal-title":"J Am Soc Nephrol"},{"key":"2605_CR4","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0140-6736(10)60670-8","volume":"376","author":"D Gale","year":"2010","unstructured":"Gale D, De Jorge E, Cook H (2010) Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet 376:794\u2013801","journal-title":"Lancet"},{"issue":"4","key":"2605_CR5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/ki.2012.80","volume":"82","author":"VD D\u2019Agati","year":"2012","unstructured":"D\u2019Agati VD, Bomback AS (2012) C3 glomerulopathy: what\u2019s in a name ? Kidney Int 82(4):379\u2013381","journal-title":"Kidney Int"},{"issue":"4","key":"2605_CR6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semnephrol.2011.06.005","volume":"31","author":"S Sethi","year":"2011","unstructured":"Sethi S, Fervenza F (2011) Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification. Semin Nephrol 31(4):341\u2013348","journal-title":"Semin Nephrol"},{"key":"2605_CR7","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1681\/ASN.2005010078","volume":"16","author":"G Appel","year":"2005","unstructured":"Appel G, Cook H, Hageman G, Jennette J, Kashgarian M, Kirschfink M, Lambris J, Lanning L, Lutz H, Meri S, Rose N, Salant D, Sethi S, Smith R, Smoyer W, Tully H, Tully S, Walker P, Welsh M, W\u00fcrzner R, Zipfel P (2005) Membranoproliferative glomerulonephritis type II (Dense Deposit Disease): an update. J Am Soc Nephrol 16:1392\u20131404","journal-title":"J Am Soc Nephrol"},{"key":"2605_CR8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jmg.2006.045328","volume":"44","author":"A Servais","year":"2007","unstructured":"Servais A, Fremeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, Gr\u00fcnfeld JP, Lesavre P, No\u00ebl LH, Fakhouri F (2007) Primary gloemrulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet 44:193\u2013199","journal-title":"J Med Genet"},{"issue":"9","key":"2605_CR9","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/ki.2008.657","volume":"75","author":"S Sethi","year":"2009","unstructured":"Sethi S, Gamez J, Vrana J, Theis J, Ill H, Zipfel P, Dogan A, Smith R (2009) Glomeruli of dense deposit disease contain components of the alternative and terminal complement pathway. Kidney Int 75(9):952\u2013960","journal-title":"Kidney Int"},{"key":"2605_CR10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00467-010-1734-4","volume":"26","author":"V Leroy","year":"2011","unstructured":"Leroy V, Fremeaux-Bacchi V, Peuchmaur M, Baudouin V, Deschenes G, Macher MA, Loirat C (2011) Membranoproliferative glomerulonephritis with C3nef and genetic complement dysregulation. Pediatr Nephrol 26:419\u2013424","journal-title":"Pediatr Nephrol"},{"issue":"17","key":"2605_CR11","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199804233381707","volume":"338","author":"S Orth","year":"1998","unstructured":"Orth S, Ritz E (1998) The nephrotic syndrome. N Engl J Med 338(17):1202\u20131211","journal-title":"N Engl J Med"},{"issue":"1","key":"2605_CR12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s004670050232","volume":"11","author":"B Warady","year":"1997","unstructured":"Warady B, Hebert D, Sullivan E, Alexander S, Tejani A (1997) Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 11(1):49\u201364","journal-title":"Pediatr Nephrol"},{"key":"2605_CR13","unstructured":"Rapport REIN Agence Biomedecine (2010) http:\/\/www.socnephrologie.org\/REIN\/documents.htm"},{"key":"2605_CR14","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ki.2012.63","volume":"82","author":"A Servais","year":"2012","unstructured":"Servais A, No\u00ebl LH, Roumenina L, Le Quintrec M, Ngo S, Dragon-Durey MA, Macher MA, Zuber J, Karras A, Provot F, Moulin B, Gr\u00fcnfeld JP, Niaudet P, Lesavre P, Fr\u00e9meaux-Bacchi V (2012) Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int 82:454\u2013464","journal-title":"Kidney Int"},{"key":"2605_CR15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ki.2012.212","volume":"82","author":"S Sethi","year":"2012","unstructured":"Sethi S, Fervenza F, Zhang Y, Zand Y, Zand L, Vrana J, Nasr S, Theis J, Dogan A, Smith R (2012) C3 glomerulopnephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment and follow-up. Kidney Int 82:465\u2013473","journal-title":"Kidney Int"},{"key":"2605_CR16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2215\/CJN.03480708","volume":"4","author":"S Nasr","year":"2009","unstructured":"Nasr S, Valeri A, Appel G, Sherwinter J, Stokes M, Said S, Markowitz G, D\u2019Agati V (2009) Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients. Clin J Am Soc Nephrol 4:22\u201332","journal-title":"Clin J Am Soc Nephrol"},{"key":"2605_CR17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jim.2010.12.020","volume":"365","author":"L Roumenina","year":"2011","unstructured":"Roumenina L, Loirat C, Dragon-Durey M (2011) Alternative complement pathway assessment in patients with atypical HUS. J Immunol Methods 365:8\u201326","journal-title":"J Immunol Methods"},{"key":"2605_CR18","first-page":"811","volume":"9","author":"Fremeaux-Bacchi","year":"1994","unstructured":"Fremeaux-Bacchi, Weiss L, Brun P (1994) Selective disappearance of C3NeF IgG autoantibody in the plasma of patient with membranoproliferative glomerulonephritis following renal transplantation. Nephrol Dial Transplant 9:811\u2013814","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"2605_CR19","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1681\/ASN.V9122318","volume":"9","author":"N Rougier","year":"1998","unstructured":"Rougier N, Kazatchkine MD, Rougier JP, Fremeaux-Bacchi V, Blouin J, Deschenes G, Soto B, Baudouin V, Pautard B, Proesmans W, Weiss E, Weiss L (1998) Human complement factor H deficiency associated with hemolytic uremic syndrome. J Am Soc Nephrol 9(12):2318\u20132326","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"2605_CR20","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00467-009-1322-7","volume":"25","author":"B Alchi","year":"2009","unstructured":"Alchi B, Jayne D (2009) Membranoproliferative glomerulonephritis. Pediatr Nephrol 25(8):1409\u20131418","journal-title":"Pediatr Nephrol"},{"key":"2605_CR21","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMra1108178","volume":"366","author":"S Sethi","year":"2012","unstructured":"Sethi S, Fervenza F (2012) Membranoproliferative glomerulonephritis\u2014A new look at an old entity. N Engl J Med 366:1119\u20131131","journal-title":"N Engl J Med"},{"issue":"2","key":"2605_CR22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0002-9343(83)90606-X","volume":"74","author":"J Cameron","year":"1983","unstructured":"Cameron J, Turner D, Heaton J, Williams D, Ogg C, Chantler C, Haycock G, Hicks J (1983) Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis. Am J Med 74(2):175\u2013192","journal-title":"Am J Med"},{"issue":"6","key":"2605_CR23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0272-6386(89)80004-6","volume":"13","author":"W Bennett","year":"1989","unstructured":"Bennett W, Fassett R, Walker R, Fairley K, D\u2019Apice A, Kincaid-Smith P (1989) Mesangiocapillary glomerulonephritis type II (dense deposit disease): clinical features of progressive disease. Am J Kidney Dis 13(6):469\u2013476","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2605_CR24","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.ki.5000084","volume":"69","author":"M Little","year":"2006","unstructured":"Little M, Dupont P, Campbell E, Dorman A, Walshe J (2006) Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Kidney Int 69(3):504\u2013511","journal-title":"Kidney Int"},{"issue":"12","key":"2605_CR25","first-page":"1747","volume":"9","author":"V Fremeaux-Bacchi","year":"1994","unstructured":"Fremeaux-Bacchi V, Weiss L, Demouchy C, May A, Palomera S, Kazatchkine M (1994) Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic (C3NeF) IgG autoantibody activity. Nephrol Dial Transplant 9(12):1747\u20131750","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2605_CR26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ki.2012.384","volume":"83","author":"S Sethi","year":"2013","unstructured":"Sethi S, Fervenza F, Zhang Y, Zand L, Meyer N, Borsa N, Nasr S, Smith R (2013) Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement. Kidney Int 83(2):293\u2013299","journal-title":"Kidney Int"},{"issue":"1","key":"2605_CR27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.ajkd.2012.02.329","volume":"60","author":"K Vernon","year":"2012","unstructured":"Vernon K, Goicoechea de Jorge E, Hall AE, Fremeaux-Bacchi V, Aitman TJ, Cook HT, Hangartner R, Koziell A, Pickering MC (2012) Acute presentation and persistent glomerulonephritis following streptococcal infection in a patient with heterozygous complement factor H-related protein 5 deficiency. Am J Kidney Dis 60(1):121\u2013125","journal-title":"Am J Kidney Dis"},{"issue":"22","key":"2605_CR28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2215\/CJN.07900811","volume":"7","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Meyer N, Wang K, Nishimura C, Frees K, Jones M, Katz L, Sethi S, Smith R (2012) Causes of alternative pathway dysregulation in dense deposit disease. Clin J Am Soc Nephrol 7(22):265\u2013274","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"2605_CR29","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1128\/CMR.00048-09","volume":"23","author":"S Ram","year":"2010","unstructured":"Ram S, Lewis L, Rice P (2010) Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev 23(4):740\u2013780","journal-title":"Clin Microbiol Rev"},{"key":"2605_CR30","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1046\/j.1523-1755.1999.07006.x","volume":"70","author":"A Levin","year":"1999","unstructured":"Levin A (1999) Management of membranoproliferative glomerulonephritis: evidence-based recommendations. Kidney Int 70:S41\u2013S46","journal-title":"Kidney Int"},{"key":"2605_CR31","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/med\/9780199552887.003.0009","volume-title":"Treatment of primary glomerulonephritis","author":"RJ Glassock","year":"2009","unstructured":"Glassock RJ (2009) Membranoproliferative glomerulonephritis. In: Ponticelli C, Glassock RJ (eds) Treatment of primary glomerulonephritis, 2nd edn. Oxford University Press, Oxford, England, pp 375\u2013398","edition":"2"},{"key":"2605_CR32","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00467-011-2059-7","volume":"27","author":"D Lu","year":"2012","unstructured":"Lu D, Moon M, Lanning LD, McCarthy A, Smith R (2012) Clinical features and outcomes of 98 children and adults with dense deposit disease. Pediatr Nephrol 27:773\u2013781","journal-title":"Pediatr Nephrol"},{"key":"2605_CR33","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/S0022-3476(05)82712-X","volume":"116","author":"McEnery","year":"1990","unstructured":"McEnery (1990) Membranoproliferative glomerulonephritis: the Cincinnati experience-cumulative renal survival from 1957\u20131989. J Pediatr 116:S109\u2013S114","journal-title":"J Pediatr"},{"key":"2605_CR34","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/ki.1992.232","volume":"41","author":"D Ford","year":"1992","unstructured":"Ford D, Briscoe D, Shanley P, Lum G (1992) Childhood membranoproliferative glomerulonephritis type I: limited steroid therapy. Kidney Int 41:1606\u20131612","journal-title":"Kidney Int"},{"key":"2605_CR35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00866289","volume":"6","author":"P Tarashish","year":"1992","unstructured":"Tarashish P, Bernstain J, Tobin J, Edelmann C (1992) Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone-a report of the International Study of Kidney Disease in Children. Pediatr Nephrol 6:123\u2013130","journal-title":"Pediatr Nephrol"},{"key":"2605_CR36","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1442-200X.1995.tb03390.x","volume":"37","author":"S Emre","year":"1995","unstructured":"Emre S, Sirin A, Alpay H, Tanman F, Uvsal V, Navir A, Bilge I (1995) Pulse methylprednisolone therapy in children with membranoproliferative glomerulonephritis. Acta Paediatr Jpn 37:626\u2013629","journal-title":"Acta Paediatr Jpn"},{"key":"2605_CR37","first-page":"234","volume":"20","author":"E Bahat","year":"2007","unstructured":"Bahat E, Akkava BKS, Karpuzoglu G, Guven AG (2007) Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis. J Nephrol 20:234\u2013245","journal-title":"J Nephrol"},{"key":"2605_CR38","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/adc.55.6.446","volume":"55","author":"S Chapman","year":"1980","unstructured":"Chapman S, Cameron J, Chantler C, Turner D (1980) Treatment of mesangiocapillary glomerulonephritis in children with combined immunosuppression and anticoagulation. Arch Dis Child 55:446\u2013451","journal-title":"Arch Dis Child"},{"key":"2605_CR39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000187889","volume":"67","author":"R Faedda","year":"1994","unstructured":"Faedda R, Satta A, Tanda F, Pirisi M, Bartoli E (1994) Immunosuppressive treatment of membranoproliferative glomerulonephritis. Nephron 67:59\u201365","journal-title":"Nephron"},{"key":"2605_CR40","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1046\/j.1523-1755.2002.00214.x","volume":"61","author":"M Choi","year":"2002","unstructured":"Choi M, Eustace J, Gimenez L, Atta M, Scheel P, Sothinathan R, Briggs W (2002) Mycophenolate mofetil treatment for primary glomerular diseases. Kidney Int 61:1098\u20131114","journal-title":"Kidney Int"},{"key":"2605_CR41","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1093\/ndt\/gfh526","volume":"19","author":"G Jones","year":"2004","unstructured":"Jones G, Juazczak M, Kingdon E, Harber M, Sweny P, Burns A (2004) Treatment of idiopathic membranoproliferative glomerulonephritis with mycophenolate mofetil an steroids. Nephrol Dial Transplant 19:3160\u20133164","journal-title":"Nephrol Dial Transplant"},{"key":"2605_CR42","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1681\/ASN.V210s159","volume":"2","author":"G D\u2019Amico","year":"1992","unstructured":"D\u2019Amico G, Ferrario F (1992) Mesangiocapillary glomerulonephritis. J Am Soc Nephrol 2:S159\u2013S166","journal-title":"J Am Soc Nephrol"},{"key":"2605_CR43","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ki.2011.399","volume":"81","author":"S Sethi","year":"2012","unstructured":"Sethi S, Nester C, Smith R (2012) Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion. Kidney Int 81:434\u2013441","journal-title":"Kidney Int"},{"key":"2605_CR44","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.molimm.2011.04.005","volume":"48","author":"R Smith","year":"2011","unstructured":"Smith R, Harris C, Pickering M (2011) Dense deposit disease. Mol Immunol 48:1604\u20131610","journal-title":"Mol Immunol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-013-2605-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-013-2605-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-013-2605-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T21:52:15Z","timestamp":1646603535000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-013-2605-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,26]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["2605"],"URL":"https:\/\/doi.org\/10.1007\/s00467-013-2605-6","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,26]]}}}